share_log

Investors Five-year Losses Continue as Transfar Zhilian (SZSE:002010) Dips a Further 4.2% This Week, Earnings Continue to Decline

Investors Five-year Losses Continue as Transfar Zhilian (SZSE:002010) Dips a Further 4.2% This Week, Earnings Continue to Decline

由於傳化智聯(SZSE:002010)本週再下跌4.2%,收益繼續下降,投資者五年期虧損仍在繼續
Simply Wall St ·  06/01 20:23

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more than offset the losers At this point some shareholders may be questioning their investment in Transfar Zhilian Co., Ltd. (SZSE:002010), since the last five years saw the share price fall 41%. We also note that the stock has performed poorly over the last year, with the share price down 22%.

選股的主要目的是找到能夠跑贏市場的股票。但關鍵是要找到足夠的贏家,以彌補輸家的虧損。現在,一些股東可能會質疑自己對傳化智聯股份有限公司(SZSE:002010)的投資,因爲過去五年該公司的股價下跌了41%。同時,我們也注意到,股價在過去一年表現不佳,下跌了22%。

Since Transfar Zhilian has shed CN¥437m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.

自從傳化智聯在過去的7天裏損失了4.37億元人民幣的價值後,讓我們看看長期的衰退是否是由業務經濟推動的。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

在他的文章《格雷厄姆和多德斯維爾超級投資者》中,禾倫·巴菲特描述了股票價格並不總是反映公司價值的合理方式。考慮市場對公司的看法如何發生變化的一個不完美但簡單的方法是將每股收益(EPS)的變化與股價的變動進行比較。股票價格並不總是反映公司價值的合理方式禾倫·巴菲特曾經描述過,股價並不總是理性地反映了企業的價值。評估市場對一家公司的情緒如何變化的一個有缺陷但合理的方法是將每股收益(EPS)與股價進行比較。

During the five years over which the share price declined, Transfar Zhilian's earnings per share (EPS) dropped by 1.2% each year. This reduction in EPS is less than the 10% annual reduction in the share price. So it seems the market was too confident about the business, in the past.

在股價下跌的五年期間,傳化智聯的每股收益(EPS)每年下降了1.2%。這種EPS的下降比股價每年下跌的10%要小。因此,過去市場對該公司的業務看法過於樂觀。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖顯示了EPS隨時間變化的情況(點擊圖像以顯示確切值)。

earnings-per-share-growth
SZSE:002010 Earnings Per Share Growth June 2nd 2024
SZSE:002010每股收益增長2024年6月2日

This free interactive report on Transfar Zhilian's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

如果您想進一步調查該股票,傳化智聯的盈利、營業收入和現金流的這份免費交互式報告是一個很好的起點。

What About Dividends?

那麼分紅怎麼樣呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Transfar Zhilian, it has a TSR of -37% for the last 5 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence!

在考慮投資回報時,重要的是考慮總股東回報(TSR)和股票回報之間的差異。 TSR包括任何剝離或折讓的資本籌集(基於股息被重新投資的假設),以及任何股息。因此,對於支付慷慨的股息公司而言,TSR通常比股票回報高得多。就中國神威藥業集團而言,其TSR在過去5年中達到了75%。這超過了我們之前提到的股票回報。該公司支付的股息已經提高了總股東回報。總股東回報股票回報相比之下,股價回報僅反映了股價的變化,總股東回報率(TSR)包括股息的價值(假設已再投資)、任何打折資本籌集或剝離的利益。可以說,TSR爲支付股息的股票提供了更完整的畫面。對於傳化智聯而言,過去5年TSR爲-37%。這超過了我們之前提到的股價回報。很明顯,股息支付很大程度上解釋了這種分歧!

A Different Perspective

不同的觀點

While the broader market lost about 11% in the twelve months, Transfar Zhilian shareholders did even worse, losing 20% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 6% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 3 warning signs for Transfar Zhilian you should be aware of, and 1 of them is potentially serious.

儘管整個市場在過去的十二個月中損失了約11%,但傳化智聯的股東表現更差,損失了20%(甚至包括分紅派息)。話雖如此,在市場下跌時,有些股票被賣過頭是不可避免的。關鍵在於注意基本面的發展。遺憾的是,去年的表現又加上了一個糟糕的運行,股東面臨着五年總計6%的虧損。我們知道,羅斯柴爾德男爵曾表示投資者應該在“街上有血跡的時候買入”,但我們警告投資者首先要確定他們正在購買一個高品質的業務。雖然考慮市場狀況對股價的影響是值得考慮的,但有其他更重要的因素。就拿傳化智聯來說,我們已經發現了3個警告信號,您應該意識到其中1個可能非常嚴重。

For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找獲勝投資的人來說,最近有內部購買的低估公司免費列表可能是一個很好的選擇。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論